Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

6/2/2007 Mid-Cycle Review - Chemistry, Manufacturing, Controls - RECOTHROM

M E M O R A N D U M

Department of Health and Human Services
Public Health Service
Food and Drug Administration
Center for Biologics Evaluation and Research

Date: June 12, 2007
To: File
From: Nancy Kirschbaum
Subject: Mid-cycle review memo, STN 125248: Thrombin, Topical (Recombinant), ZymoGenetics, Inc. Original BLA, Chemistry, Manufacturing, and Controls
CC: Roman Drews
Tim Lee
Mark Shields
Nisha Jain
Nancy Waites

Drug Substance
3.2.S.1.2; 3.2.S.1.3 Structure and General Properties-

--------------   -------------------------------------------------------------------

-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------

--------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------
---------------

  • ------------------------------------------------------------
  • ------------------------------------------------------------------------
  • ----------------------------------------------------------------------

-----------------------------------------------------


18


PAGE(S)


DETERMINED


TO BE


NOT RELEASABLE

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 02/12/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.